VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog
← Value Add PulseFUNDING$35M Series A

Ex-Intel Chip Architect Raja Koduri Raises $35M for Licensable GPU/AI Chiplet Startup OXMIQ

OXMIQ Labs, led by former Intel and AMD chip architect Raja Koduri, raised a $35 million Series A co-led by Fundomo and Samsung Catalyst Fund, with MediaTek returning as an investor alongside AM Intelligence Labs, Pegatron Venture Capital, CDIB-TEN, Darwin Ventures and Morgan Creek Digital, to scale production of its licensable, CUDA-compatible OxCore chiplet architecture for AI accelerators.

$35M Series A
Round Size
$60M
Total Funding to Date
Fundomo, Samsung Catalyst Fund
Co-Lead Investors
MediaTek, AM Intelligence Labs, Pegatron VC, CDIB-TEN, Darwin Ventures, Morgan Creek Digital
Other Investors
OxCore chiplet architecture (GPU + tensor processor + CPU orchestration)
Core Product
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
July 1, 2026
2 min read
ShareXLinkedInEmail
KEY TAKEAWAYS FOR VCs & FOUNDERS
1

A licensable, CUDA-compatible GPU/AI chiplet architecture directly targets chipmakers who want an Nvidia alternative without building a full accelerator stack from scratch

2

MediaTek, a seed investor, returning for the Series A alongside Samsung's venture arm shows continued semiconductor-industry conviction in the licensing model specifically, not just a one-time bet

3

Raja Koduri's background architecting GPUs at both Intel and AMD gives OXMIQ a level of chip-design credibility that's rare even among well-funded AI hardware startups

4

Total funding reaching $60M positions OXMIQ to compete for design-win conversations with chipmakers already fielding pitches from multiple GPU-architecture licensing challengers this cycle

TC
The VC Read · Trace's TakeTrace Cohen

MediaTek re-upping from seed to Series A is the detail that actually validates this round -- semiconductor companies don't casually double down on a licensing-model chip startup unless early technical diligence or design-partner conversations are going somewhere real, and having Samsung's venture arm co-lead on top of that gives OXMIQ relationships with two major potential licensees at once. Raja Koduri's actual chip-architecture pedigree at Intel and AMD matters more here than in most AI hardware pitches, because the product being sold is literally licensable silicon design, not a software layer wrapped around someone else's chips. The CUDA-compatibility bet is the strategic crux: it's a wager that lowering chipmakers' switching cost matters more than owning a fully proprietary instruction set, in a market where Nvidia's software moat, not just its hardware, is the harder thing to displace. For hardware-adjacent founders, the MediaTek-to-Series-A conversion is a cleaner playbook than most: land a strategic chipmaker as an early believer, then let their continued backing do the credibility work with the next round of investors. Watch which chipmaker signs on as OXMIQ's first named OxCore licensee -- that's the real signal of whether this architecture gets adopted or just gets funded.

💰 VC Fundraises 2026 →🤖 AI Landscape →

OXMIQ Labs, a Campbell, California-based chip startup led by former Intel and AMD chip architect Raja Koduri, announced a $35 million Series A on July 1, 2026, co-led by Fundomo and Samsung Catalyst Fund. MediaTek, which backed the company at seed stage, returned as an investor in this round alongside AM Intelligence Labs, Pegatron Venture Capital, CDIB-TEN, Darwin Ventures and Morgan Creek Digital, bringing OXMIQ's total funding to date to $60 million.

The company builds OxCore, a licensable, single-package GPU/AI chiplet architecture that combines a CUDA-compatible GPU, a dedicated tensor processor and a CPU orchestration layer, aimed specifically at agentic AI workloads. Rather than selling finished chips directly, OXMIQ's business model licenses the underlying architecture to chipmakers who want to build their own AI accelerators without designing a full GPU stack from scratch -- a strategy that positions the company as infrastructure for other hardware makers rather than a direct-to-cloud competitor.

MediaTek's decision to return as an investor at the Series A stage, having already backed OXMIQ at seed, is a meaningful signal in its own right: semiconductor companies rarely re-up on licensing-model startups unless early technical diligence or design-partner conversations have gone well. Samsung Catalyst Fund co-leading alongside Fundomo adds a second major chipmaker's venture arm to the cap table, giving OXMIQ investor relationships with at least two of the industry's largest potential licensing customers simultaneously.

Koduri's background is central to the pitch: having architected graphics processors at both Intel and AMD across a multi-decade career, he brings a level of hands-on GPU design credibility that's uncommon even among well-capitalized AI hardware startups, many of which are led by executives with primarily software or systems backgrounds rather than deep silicon design experience.

The competitive landscape for GPU-architecture licensing has grown more crowded through 2026 as more startups pursue Nvidia-alternative positioning for chipmakers who don't want to build accelerator architectures independently or remain fully dependent on Nvidia's own roadmap and pricing. OXMIQ's bet is that a CUDA-compatible approach specifically -- rather than a wholly proprietary instruction set -- lowers the switching cost enough for chipmakers to seriously evaluate licensing OxCore instead of building in-house.

For semiconductor and AI-infrastructure investors, OXMIQ's round is a useful data point on how much capital and credibility a licensable, CUDA-compatible architecture can attract when helmed by an executive with genuine chip-design pedigree. For founders in adjacent hardware categories, MediaTek's repeat investment underscores that landing a strategic chipmaker as a seed investor and converting them into a Series A backer is one of the strongest signals available that early design-partner conversations are translating into real commercial interest.

What to watch: which chipmakers OXMIQ signs as its first public OxCore licensing customers, how the architecture's CUDA compatibility holds up against Nvidia's own evolving software moat, and whether OXMIQ's dual backing from MediaTek and Samsung -- two competing device makers -- creates any tension over exclusivity as the company approaches its first commercial licensing deals.

ShareXLinkedInEmail

Originally reported by Business Wire. Analysis and editorial commentary by Value Add Pulse.

← Back to Pulse

Read Next

FUNDINGNew firm targets AI infra, energy, deep tech

Ashton Kutcher Leaves Sound Ventures to Launch a New Firm With Morgan Beller

Ashton Kutcher is departing Sound Ventures, the firm he co-founded 11 years ago with Guy Oseary, to launch a new early-stage firm with Morgan Beller -- a former Andreessen Horowitz partner and NFX general partner who also co-led Meta's Libra cryptocurrency project -- targeting AI infrastructure, energy and deep tech, TechCrunch reported July 1. The new firm's name and fund size have not yet been disclosed, and Kutcher will remain an adviser to Sound Ventures while Oseary and GP Effie Epstein advise the new firm.

FUNDING$54.2M Series B

Nobel Laureate's Qolab Raises $54.2M Series B to Scale Superconducting Quantum Chips

Qolab, a Santa Barbara superconducting-quantum-processor startup co-founded by 2025 Nobel physics laureate John Martinis, closed a $54.2 million Series B led by UC Investments on July 2, with WARF, Octave Ventures and Phoenix Venture Partners also participating, to fund semiconductor fabrication partnerships and manufacturing scale-up toward fault-tolerant quantum computing.

FUNDING$180M Series B

Celea Therapeutics Raises $180M Series B for Pulmonary Fibrosis Drug

Celea Therapeutics, a clinical-stage biotech spun out of PureTech developing deupirfenidone for idiopathic pulmonary fibrosis, announced a $180 million Series B on July 2, led by RA Capital and Leaps by Bayer, with PureTech and additional unnamed health-focused and sovereign funds participating, per weekly funding roundups covering the deal.

@Trace_Cohen·t@nyvp.com